$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for m 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • C07K-003/00
  • C12N-009/96
  • C08G-065/32
출원번호 US-0151481 (1993-11-12)
발명자 / 주소
  • Harris J. Milton (Huntsville AL)
출원인 / 주소
  • Shearwater Polymers, Inc. (Huntsville AL 02)
인용정보 피인용 횟수 : 253  인용 특허 : 0

초록

A poly(ethylene glycol) derivative is disclosed that is activated with a sulfone moiety for selective attachment to thiol moieties on molecules and surfaces. The activated PEG is water soluble, hydrolytically stable for extended periods, and forms hydrolytically stable linkages with thiol moieties.

대표청구항

An activated poly(ethylene glycol) derivative having the structure: R-CH2CH2-(OCH2CH2)n-Y wherein n equals 5 to 3,000, Y is -SO2-CH〓CH2, and R is selected from the group consisting of HO-, H3CO-, X-CH2-CH2-SO2-, where X is halogen, and CH2〓CH-SO2-.

이 특허를 인용한 특허 (253)

  1. Sawhney, Amarpreet S.; Ransone, II, William H., Adhesive hydrogels for ophthalmic drug delivery.
  2. Shepard, Harold Michael; Thompson, Curtis; Li, Xiaoming; Frost, Gregory I., Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects.
  3. DeFrees, Shawn; Wang, Zhi-Guang, Antibody toxin conjugates.
  4. Cho, Ho Sung; Daniel, Thomas O.; Wilson, Troy E.; Cujec, Thomas P.; Tian, Feng; Hays, Anna Maria; Kimmel, Bruce E.; Ho, Lillian, Antigen-binding polypeptides and their uses.
  5. Cho, Ho Sung; Daniel, Thomas O.; Wilson, Troy E.; Cujec, Thomas P.; Tian, Feng; Hays, Anna-Maria A.; Kimmel, Bruce E.; Ho, Lillian, Antigen-binding polypeptides and their uses.
  6. Desjarlais, John R.; Thomason, Adam Read; Zhukovsky, Eugene Alexander, BAFF variants and methods thereof.
  7. Walensky, Loren D.; Stewart, Michelle L.; Barclay, Lauren, BH4 stabilized peptides and uses thereof.
  8. Sawhney, Amarpreet S.; Bennett, Steven; Edelman, Peter G., Biocompatible hydrogels made with small molecule precursors.
  9. Pathak, Chandrashekhar P.; Sawhney, Amarpreet S.; Edelman, Peter G., Biocompatible polymers and hydrogels and methods of use.
  10. Hubbell, Jeffrey A.; Elbert, Donald; Lütolf, Matthias; Pratt, Alison; Schoenmakers, Ronald; Tirelli, Nicola; Vernon, Brent, Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups.
  11. Sarangapani Shantha ; Calvert Paul D., Biomimetic calcium phosphate implant coatings and methods for making the same.
  12. Cho, Ho Sung; Daniel, Thomas O.; Hays, Anna Maria; Wilson, Troy E.; Litzinger, David C.; Mariani, Roberto; Kimmel, Bruce E.; Keefe, William M., Biosynthetic polypeptides utilizing non-naturally encoded amino acids.
  13. Dixon, James Brandon; Hubbell, Jeffrey A.; O'Neil, Conlin P.; Swartz, Melody; Velluto, Diana, Block copolymers and uses thereof.
  14. Hubbell,Jeffrey A.; Napoli,Alessandro; Tirelli,Nicola, Block copolymers for multifunctional self-assembled systems.
  15. DeFrees, Shawn, Branched PEG remodeling and glycosylation of glucagon-like peptide-1 [GLP-1].
  16. DeFrees, Shawn, Branched water-soluble polymers and their conjugates.
  17. DeFrees, Shawn, Branched water-soluble polymers and their conjugates.
  18. Tamarkin, Lawrence; Paciotti, Giulio F., Colloidal metal compositions and methods.
  19. Tamarkin, Lawrence; Paciotti, Giulio F., Colloidal metal compositions and methods.
  20. Bendele Alison M. ; Sennello Regina M. ; Edwards III Carl K., Combination therapy using a TNF binding protein for treating TNF-mediated diseases.
  21. Maneval, Daniel C.; Shepard, H. Michael; Thompson, Curtis B., Combination therapy with an anti-hyaluronan agent and therapeutic agent.
  22. Maneval, Daniel C.; Shepard, H. Michael; Thompson, Curtis B., Combination therapy with an anti-hyaluronan agent and therapeutic agent.
  23. Jiang, Ping; Shepard, H. Michael; Huang, Lei, Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof.
  24. Jiang, Ping; Shepard, H. Michael; Huang, Lei, Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof.
  25. Sawhney, Amarpreet S., Composite hydrogel drug delivery systems.
  26. Sawhney, Amarpreet S., Composite hydrogel drug delivery systems.
  27. Sawhney,Amarpreet S., Composite hydrogel drug delivery systems.
  28. Li, Xiaoming; Ramprasad, Mysore; Thompson, Curtis; Shepard, Harold Michael; Bookbinder, Louis Howard; Frost, Gregory Ian, Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia.
  29. Paciotti, Giulio F.; Raghunandan, Ramadevi; Huhta, Marja S.; Tamarkin, Lawrence, Compositions and methods for generating antibodies.
  30. Walker, Kenneth W.; Gegg, Jr., Colin V., Compositions and methods for producing bioactive fusion proteins.
  31. Raines, Ronald T.; Rutkoski, Thomas J.; Kink, John A.; Strong, Laura E., Compositions and methods for ribonuclease-based therapeutics.
  32. DeFrees, Shawn, Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants.
  33. Molenberg, Aaldert Rens; Zamparo, Enrico; Rapillard, Laurent; Cerritelli, Simona, Compositions for tissue augmentation.
  34. Thanos, Christopher D.; Wang, Lin; Shepard, H. Michael, Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same.
  35. Paulsel, Andrew; Cho, Ho Sung, Compositions of aminoacyl-tRNA synthetase and uses thereof.
  36. Paulsel, Andrew; Cho, Ho Sung, Compositions of aminoacyl-tRNA synthetase and uses thereof.
  37. Paulsel, Andrew; Cho, Ho Sung, Compositions of aminoacyl-tRNA synthetase and uses thereof.
  38. Paulsel, Andrew; Cho, Ho Sung, Compositions of aminoacyl-tRNA synthetase and uses thereof.
  39. Paulsel, Andrew; Cho, Ho Sung, Compositions of aminoacyl-tRNA synthetase and uses thereof.
  40. Tian, Feng, Compositions of tRNA and uses thereof.
  41. Kudirka, Romas Alvydas; Albers, Aaron Edward; Rabuka, David, Compounds and methods for producing a conjugate.
  42. Hubbell, Jeffrey A.; Elbert, Donald L.; Schoenmakers, Ronald, Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds.
  43. Hubbell,Jeffrey A.; Elbert,Donald; Schoenmakers,Ronald, Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds.
  44. Hubbell,Jeffrey A.; Elbert,Donald; Schoenmakers,Ronald, Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds.
  45. Bolt, Gert; Vandahl, Brian Berg Stidsen; Thim, Lars; Stennicke, Henning Ralf; Steenstrup, Thomas Dock; DeFrees, Shawn, Conjugated factor VIII molecules.
  46. Godwin, Antony Robert; Brocchini, Stephen James, Conjugated proteins and peptides.
  47. Godwin, Antony Robert; Brocchini, Stephen James, Conjugated proteins and peptides.
  48. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P.; Nguyen, Hung Q.; Walker, Kenneth W.; Hu, Shaw-Fen Sylvia; Gegg, Jr., Colin V.; Khare, Taruna Arora; Adler, Beverly S.; Martin, Francis H., Conjugated toxin peptide therapeutic agents.
  49. Prakash, Ramesh K.; Clemens, Christopher M., Conjugates targeted to the interleukin-2 receptor.
  50. Havenstrite, Karen L.; McCray, Victor Wayne; Felkins, Brandon McNary; Ackermann, Douglas Michael; Smith, Garrett Cale; Cook, Paul A.; Luxon, Evan S.; McGibbon, Andrew A., Contact lens with a hydrophilic layer.
  51. Havenstrite, Karen L.; McCray, Victor Wayne; Felkins, Brandon McNary; Cook, Paul A., Contact lens with a hydrophilic layer.
  52. Pathak,Chandrashekhar P., Crosslinked albumin hydrogels.
  53. Pathak, Chandrashekhar P., Crosslinking agents and methods of use.
  54. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P.; Nguyen, Hung Q.; Walker, Kenneth W.; Hu, Shaw-Fen Sylvia; Gegg, Jr., Colin V., DNA encoding OSK1 toxin peptide analogs and vectors and cells for combinant expression.
  55. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P.; Nguyen, Hung Q.; Walker, Kenneth W.; Hu, Shaw-Fen Sylvia; Gegg, Jr., Colin V.; Arora Khare, Taruna; Adler, Beverly S.; Martin, Francis H., DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression.
  56. Bennett, Steven L., Drug delivery device.
  57. Jarrett, Peter; El-Hayek, Rami; Sawhney, Amarpreet S.; Guedez, Sarah, Drug delivery systems and applications.
  58. Jarrett, Peter; Bassett, Michael; Blizzard, Charles D.; Sawhney, Amarpreet S., Drug delivery through hydrogel plugs.
  59. Sawhney, Amarpreet S.; Jarrett, Peter; Bassett, Michael; Blizzard, Charles, Drug delivery through hydrogel plugs.
  60. McIver John McMillan ; Underiner Todd Laurence ; Bates Timothy, Enzyme inhibitors.
  61. DeFrees, Shawn; Zopf, David A.; Bayer, Robert J.; Bowe, Caryn; Hakes, David James; Chen, Xi, Erythropoietin: remodeling and glycoconjugation of erythropoietin.
  62. Wei, Ge; Selvam, Krishnasamy Panneer; Bookbinder, Louis; Frost, Gregory I., Extended soluble PH20 polypeptides and uses thereof.
  63. DeFrees, Shawn; Zopf, David; Bayer, Robert; Bowe, Caryn; Hakes, David; Chen, Xi, Factor VII: remodeling and glycoconjugation of Factor VII.
  64. DeFrees, Shawn; Zopf, David A.; Bayer, Robert J.; Bowe, Caryn; Hakes, David James; Chen, Xi, Factor VIII: remodeling and glycoconjugation of factor VIII.
  65. Hays, Anna-Maria A.; Buechler, Ying; Litzinger, David C., Formulations of human growth hormone comprising a non-naturally encoded amino acid.
  66. Hays, Anna-Maria; Buechler, Ying; Litzinger, David C., Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35.
  67. DeFrees, Shawn; Bayer, Robert J.; Zopf, David A., Glycopegylated erythropoietin.
  68. DeFrees, Shawn; Zopf, David A.; Bowe, Caryn Lang, Glycopegylated erythropoietin.
  69. DeFrees, Shawn; Bayer, Robert J.; Zopf, David A.; Kang, Jichao; Willett, Walter Scott, Glycopegylated erythropoietin formulations.
  70. DeFrees, Shawn; Bayer, Robert J.; Bowe, Caryn L.; Panneerselvam, Krishnasamy, Glycopegylated factor IX.
  71. DeFrees, Shawn; Bayer, Robert J.; Bowe, Caryn; Paneerselvam, Krishnasamy, Glycopegylated factor IX.
  72. DeFrees, Shawn; Bayer, Robert J.; Bowe, Caryn; Panneer-Selvam, Krishnasamy, Glycopegylated factor IX.
  73. DeFrees, Shawn; Clausen, Henrik; Zopf, David A.; Bowe, Caryn; Taudte, Susann; Felo, Michael; Willett, Walter S., Glycopegylated granulocyte colony stimulating factor.
  74. DeFrees, Shawn; Zopf, David A.; Clausen, Henrik; Xing, Ruye, Glycopegylated interferon α.
  75. DeFrees, Shawn; Zopf, David A.; Bayer, Robert J.; Hakes, David James; Bowe, Caryn L.; Chen, Xi, Glycopegylation methods and proteins/peptides produced by the methods.
  76. DeFrees, Shawn; Zopf, David A.; Bayer, Robert J.; Hakes, David James; Bowe, Caryn; Chen, Xi, Glycopegylation methods and proteins/peptides produced by the methods.
  77. DeFrees, Shawn, Glycosylation of peptides via O-linked glycosylation sequences.
  78. DeFrees, Shawn; Zopf, David A.; Bayer, Robert J.; Bowe, Caryn; Hakes, David James; Chen, Xi, Granulocyte colony stimulating factor: remodeling and glycoconjugation G-CSF.
  79. DeAngelis, Paul L.; Pummill, Phillip; Visser, Regina C., High molecular weight heparosan polymers and methods of production and use thereof.
  80. DeAngelis, Paul L.; Pummill, Phillip; Visser, Regina C., High molecular weight heparosan polymers and methods of production of use thereof.
  81. Cho, Ho Sung; Daniel, Thomas O.; DiMarchi, Richard D.; Hays, Anna-Maria; Wilson, Troy E.; Sim, Bee-Cheng; Litzinger, David C., Human growth hormone modified at position 35.
  82. Tian, Feng; Norman, Thea; Chu, Stephanie, Hybrid suppressor tRNA for vertebrate cells.
  83. Kudirka, Romas Alvydas; Albers, Aaron Edward; Barfield, Robyn M.; Rabuka, David, Hydrazinyl-indole compounds and methods for producing a conjugate.
  84. Kudirka, Romas Alvydas; Albers, Aaron Edward; Barfield, Robyn M.; Rabuka, David, Hydrazinyl-indole compounds and methods for producing a conjugate.
  85. Sawhney, Amarpreet S.; Ransone, II, William H., Hydrogel polymeric compositions and methods.
  86. Sawhney, Amarpreet S.; Ransone, II, William H., Hydrogel polymeric compositions and methods.
  87. Sawhney, Amarpreet S.; Ransone, II, William H., Hydrogel polymeric compositions and methods.
  88. Pathak, Chandrashekhar P., Hydrogels for protein concentration.
  89. Shepard, H. Michael; Li, Xiaoming; Thompson, Curtis, Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods.
  90. Blair, Henry; Beck, Thomas; Ladner, Robert C., Kallikrein inhibitors and anti-thrombolytic agents and uses thereof.
  91. Blair, Henry; Beck, Thomas; Ladner, Robert Charles, Kallikrein inhibitors and anti-thrombolytic agents and uses thereof.
  92. Markland, William; Ladner, Robert C., Kallikrein-binding “kunitz domain” proteins and analogues thereof.
  93. Ladner, Robert C.; Ley, Arthur C.; Hirani, Shirish; Williams, Anthony; Grazia De Simoni, Maria; Bergamaschini, Luigi, Kallikrein-inhibitor therapies.
  94. Hinderer, Walter; Scheckermann, Christian, Liquid formulation of G-CSF conjugate.
  95. Hinds, Kenneth; Lewis, Danny; Schmidt, Paul; Campbell, Kathleen M., Materials and methods for preparing protein-polymer conjugates.
  96. Jarrett, Peter; El-Hayek, Rami; Sawhney, Amarpreet S., Medical organogel processes and compositions.
  97. Jarrett, Peter; El Hayek, Rami; Bassett, Michael; Biggins, James, Method for applying flowable hydrogels to a cornea.
  98. Tamarkin, Lawrence; Paciotti, Giulio, Method for delivering a cytokine using a colloidal metal.
  99. Zhang, Wen, Method for preparing a polymer conjugate.
  100. Zhang, Wen, Method for preparing a polymer conjugate.
  101. Zhang, Wen, Method for preparing a polymer conjugate.
  102. Kozlowski, Antoni, Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid.
  103. Kozlowski, Antoni, Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid.
  104. Kozlowski, Antoni, Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid.
  105. Kozlowski, Antoni, Method for preparing water-soluble polymer derivatives bearing an N-succinimidyl ester.
  106. Kraynov, Vadim; Knudsen, Nick; Hewet, Amha; De Dios, Kristine; Pinkstaff, Jason; Sullivan, Lorraine, Method of treating heart failure with modified relaxin polypeptides.
  107. Sexton, Daniel J.; Viswanathan, Malini, Method of treating hereditary angioedema using plasma kallikrein binding antibodies.
  108. Miao, Zhenwei; Tian, Feng; Hays Putnam, Anna-Maria A.; Buechler, Ying, Methods and compositions comprising non-natural amino acids.
  109. Lewis, Danny; Schmidt, Paul; Hinds, Kenneth, Methods and compositions for enhanced delivery of bioactive molecules.
  110. Tamarkin, Lawrence; Paciotti, Giulio F., Methods and compositions for enhancing immune response and for the production of in vitro Mabs.
  111. Kink, John A.; Strong, Laura E.; Shahan, Mark N., Methods and compositions for the treatment of cancer.
  112. Kink, John A; Strong, Laura E.; Shahan, Mark N., Methods and compositions for the treatment of cancer.
  113. Buechler, Ying; Lieu, Ricky; Ong, Michael; Bussell, Stuart; Knudsen, Nick; Cho, Ho Sung, Methods for expression and purification of recombinant human growth hormone.
  114. Pathak, Chandrashekhar P., Methods for preparation of platelet rich plasma.
  115. Desjarlais, John R.; Zalevsky, Jonathan; Moore, Gregory L., Methods for rational pegylation of proteins.
  116. Desjarlais, John Rudolph; Zalevsky, Jonathan, Methods for rational pegylation of proteins.
  117. DeFrees, Shawn; Kinealy, Kyle, Methods for the purification of polypeptide conjugates comprising polyalkylene oxide using hydrophobic interaction chromatography.
  118. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Methods for treating a disease characterized by an excess of hyaluronan by administering a soluble hyaluronidase glycoprotein (sHASEGP).
  119. Cujec, Thomas P.; Mariani, Roberto; Hays Putnam, Anna-Maria A.; Keefe, William M.; Knudsen, Nick; Skidmore (Nee Ho), Lillian; Pinkstaff, Jason; Kraynov, Vadim, Methods of making FGF-21 mutants comprising non-naturally encoded phenylalanine derivatives.
  120. Keller, Gilbert; Frost, Gregory I., Methods of treatment of cellulite.
  121. Keller, Gilbert; Frost, Gregory I., Methods of treatment of collagen-mediated diseases and conditions.
  122. Zopf, David A.; Lubenau, Heinz, Methods of treatment using glycopegylated G-CSF.
  123. Cujec, Thomas P.; Mariani, Roberto; Hays Putnam, Anna-Maria A.; Keefe, Wiliam M.; Knudsen, Nick; Skidmore, Lillian; Pinkstaff, Jason; Kraynov, Vadim, Methods of treatment using modified FGF-21 polypeptides comprising non-naturally occurring amino acids.
  124. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P., Methods of using OSK1 peptide analogs.
  125. Carvalho, Bruce L.; Sheppard, Jr., Norman F.; Feakes, Christina; Kellogg, Gregory J., Microfluidics devices and methods for performing cell based assays.
  126. Cujec, Thomas P.; Mariani, Roberto; Hays Putnam, Anna-Maria A.; Keefe, William M.; Knudsen, Nick; Ho, Lillian; Pinkstaff, Jason; Kraynov, Vadim, Modified FGF-21 polypeptides and their uses.
  127. Morin, Paul E.; Cohen, Daniel; Mukherjee, Ranjan; Reilly, Timothy P.; Christian, Rose C.; Lipovsek, Dasa; Camphausen, Ray; Krupinski, John, Modified FGF-21 polypeptides comprising an internal deletion and uses thereof.
  128. Morin, Paul E.; Cohen, Daniel; Mukherjee, Ranjan; Reilly, Timothy P.; Christian, Rose C.; Lipovsek, Dasa; Camphausen, Ray; Krupinski, John, Modified FGF-21 polypeptides comprising an internal deletion and uses thereof.
  129. Cujec, Thomas P.; Mariani, Roberto; Hays Putnam, Anna-Maria A.; Keefe, William M.; Knudsen, Nick; Ho, Lillian; Pinkstaff, Jason; Kraynov, Vadim, Modified FGF-21 polypeptides comprising non-naturally occurring amino acids.
  130. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  131. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  132. Gegg, Colin V.; Walker, Kenneth W.; Miranda, Leslie P.; Xiong, Fei, Modified Fc molecules.
  133. Tian, Feng; Hays Putnam, Anna-Maria A.; Song, Frank; Chu, Stephanie; Sheffer, Joseph; Barnett, Richard S.; Siladi, Marc E.; Atkinson, Kyle; Lee, Darin; Canning, Peter C., Modified animal erythropoietin polypeptides and their uses.
  134. Tian, Feng; Hays Putnam, Anna-Maria A.; Song, Frank; Chu, Stephanie; Sheffer, Joseph; Barnett, Richard S.; Siladi, Marc; Atkinson, Kyle; Lee, Darin; Canning, Peter C., Modified animal erythropoietin polypeptides and their uses.
  135. Tian, Feng; Hays Putnam, Anna-Maria A.; Song, Frank; Chu, Stephanie; Sheffer, Joseph; Barnett, Richard S.; Siladi, Marc; Atkinson, Kyle; Lee, Darin; Canning, Peter C., Modified animal erythropoietin polypeptides and their uses.
  136. Tian, Feng; Hays Putnam, Anna-Maria A.; Song, Frank; Chu, Stephanie; Sheffer, Joseph; Barnett, Richard S.; Siladi, Marc; Atkinson, Kyle; Lee, Darin; Canning, Peter C., Modified animal erythropoietin polypeptides and their uses.
  137. Hays Putnam, Anna-Maria A.; Knudsen, Nick; Norman, Thea; Koder, Alan; Kraynov, Vadim; Ho, Lillian; Canning, Peter C., Modified bovine G-CSF polypeptides and their uses.
  138. Cho, Ho Sung; Daniel, Thomas O.; DiMarchi, Richard D.; Hays, Anna-Maria; Wilson, Troy E.; Sim, Bee-Cheng; Litzinger, David C., Modified human four helical bundle polypeptides and their uses.
  139. Cho, Ho Sung; Daniel, Thomas O.; DiMarchi, Richard D.; Hays, Anna-Maria; Wilson, Troy E.; Sim, Bee-Cheng; Litzinger, David C., Modified human four helical bundle polypeptides and their uses.
  140. Cho, Ho Sung; Daniel, Thomas O.; Dimarchi, Richard D.; Hays, Anna-Maria A.; Wilson, Troy E.; Sim, Bee-Cheng; Litzinger, David C., Modified human four helical bundle polypeptides and their uses.
  141. Cho, Ho Sung; Daniel, Thomas O.; DiMarchi, Richard D.; Hays, Anna-Maria A.; Wilson, Troy E.; Sim, Bee-Cheng; Litzinger, David C., Modified human growth hormone.
  142. Hays, Anna-Maria; Buechler, Ying; Litzinger, David C., Modified human growth hormone formulations with an increased serum half-life.
  143. Cho, Ho Sung; Daniel, Thomas O.; Hays Putnam, Anna-Maria A.; Wilson, Troy E., Modified human interferon polypeptides and their uses.
  144. Cho, Ho Sung; Daniel, Thomas O.; Hays, Anna-Maria; Wilson, Troy E., Modified human interferon polypeptides and their uses.
  145. Cho, Ho Sung; Daniel, Thomas O.; Hays, Anna-Maria A.; Wilson, Troy E., Modified human interferon polypeptides with at least one non-naturally encoded amino acid and their uses.
  146. Sheffer, Joseph; Norman, Thea; Dimarchi, Richard D.; Hays Putnam, Anna-Maria A.; Tian, Feng; Chu, Stephanie; Krawitz, Denise; Cho, Ho Sung, Modified human plasma polypeptide or Fc scaffolds and their uses.
  147. Sheffer, Joseph; Norman, Thea; Dimarchi, Richard D.; Hays Putnam, Anna-Maria A.; Tian, Feng; Chu, Stephanie; Krawitz, Denise; Cho, Ho Sung, Modified human plasma polypeptide or Fc scaffolds and their uses.
  148. Sheffer, Joseph; Norman, Thea; Dimarchi, Richard D.; Hays Putnam, Anna-Maria A.; Tian, Feng; Chu, Stephanie; Krawitz, Denise; Cho, Ho Sung, Modified human plasma polypeptide or Fc scaffolds and their uses.
  149. Miao, Zhenwei; Krawitz, Denise; Kraynov, Vadim; Tian, Feng; Sim, Bee-Cheng; Skidmore, Lillian; Hays Putnam, Anna-Maria A.; Knudsen, Nick; Deguzman, Michael, Modified insulin polypeptides and their uses.
  150. Kraynov, Vadim; Knudsen, Nick; Hays Putnam, Anna-Maria A.; Krawitz, Denise; Pinkstaff, Jason; Myler, Heather, Modified interferon beta polypeptides and their uses.
  151. Kraynov, Vadim; Hays Putnam, Anna-Maria A.; Knudsen, Nick; Pinkstaff, Jason; Myler, Heather; Sullivan, Lorraine, Modified leptin polypeptides and their uses.
  152. Feige,Ulrich, Modified peptides as therapeutic agents.
  153. Weisgerber David J. ; Rubingh Donn N., Modified polypeptides with high activity and reduced allergenicity.
  154. Kink, John A.; Strong, Laura E.; Trubetskoy, Vladimir; Shahan, Mark N., Modified ribonucleases.
  155. Wei, Ge; Selvam, Krishnasamy Panneer; Bookbinder, Louis; Frost, Gregory I., Neutral active soluble truncated PH20 polypeptides and uses thereof.
  156. Tian, Feng; Hehli, Brad, Non-natural amino acid replication-dependent microorganisms and vaccines.
  157. Tian, Feng; Hehli, Brad, Non-natural amino acid replication-dependent microorganisms and vaccines.
  158. Strong, Laura E.; Leland, Peter A.; Burke, Thomas, Non-natural ribonuclease conjugates as cytotoxic agents.
  159. Strong, Laura E.; Leland, Peter A.; Burke, Thomas, Non-natural ribonuclease conjugates as cytotoxic agents.
  160. Strong, Laura E.; Leland, Peter A.; Burke, Thomas, Non-natural ribonuclease conjugates as cytotoxic agents.
  161. Cujec, Thomas P.; Mariani, Roberto; Hays Putnam, Anna-Maria A.; Keefe, William M.; Knudsen, Nick; Skidmore, Lillian; Pinkstaff, Jason; Kraynov, Vadim, Nucleic acids encoding modified FGF-21 polypeptides comprising non-naturally occurring amino acids.
  162. Kraynov, Vadim; Knudsen, Nick; Hewet, Ahma; De Dios, Kristine; Pinkstaff, Jason; Sullivan, Lorraine, Nucleic acids encoding modified relaxin polypeptides.
  163. Fisher, Eric; Edwards, III, Carl; Kieft, Gary, Nucleic acids encoding truncated soluble tumor necrosis factor.
  164. Felo, Michael; DeFrees, Shawn, Nucleotide sugar purification using membranes.
  165. DeFrees, Shawn; Zopf, David A.; Wang, Zhi-Guang; Clausen, Henrik, O-linked glycosylation of peptides.
  166. DeFrees,Shawn; Zopf,David A.; Wang,Zhi Guang; Clausen,Henrik, O-linked glycosylation of peptides.
  167. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P., OSK1 peptide analogs and pharmaceutical compositions.
  168. DeFrees, Shawn; Zopf, David A.; Taudte, Susann; Willett, Walter Scott; Bayer, Robert J.; Kalo, Matthew, One pot desialylation and glycopegylation of therapeutic peptides.
  169. Kozlowski, Antoni, Orthoester compound.
  170. Desjarlais, John R.; Zalevsky, Jonathan, PEGylated TNF-α variant proteins.
  171. Thompson, Robert C.; Brewer, Michael T.; Kohno, Tadahiko, PEGylation reagents and compounds formed therewith.
  172. Wei, Ge; Shepard, H. Michael; Zhao, Qiping; Connor, Robert James, PH20 polypeptide variants, formulations and uses thereof.
  173. Klausen, Niels Kristian; Bjorn, Soren; Behrens, Carsten; Garibay, Patrick William, Pegylated factor VII glycoforms.
  174. Hays, Anna-Maria A.; Kimmel, Bruce E.; Cho, Ho Sung; Sim, Bee-Cheng; Litzinger, David C.; Mariani, Roberto; Kraynov, Vadim; Knudsen, Nick; Daniel, Thomas O.; Koder, Alan; Bussell, Stuart; Liu, Junjie; Miao, Zhenwei; Morrow, Theresa, Pegylated human interferon polypeptides.
  175. David John Weisgerber ; Andrew Campbell Allcock, Personal care compositions containing active proteins tethered to a water insoluble substrate.
  176. Weisgerber David John ; Allcock Andrew Campbell, Personal care compositions containing subtilisin enzymes bound to water insoluble substrates.
  177. Bertozzi, Carolyn; Agarwal, Paresh; Sletten, Ellen M., Pictet-Spengler ligation for protein chemical modification.
  178. Sexton, Daniel J.; Viswanathan, Malini, Plasma kallikrein binding proteins.
  179. Ley, Arthur C.; Sato, Aaron K; Ladner, Robert C.; Stochl, Mark, Poly-pegylated protease inhibitors.
  180. Saifer, Mark G. P.; Martinez, Alexa L.; Williams, L. David; Sherman, Merry R., Polymer conjugates of interferon-beta with enhanced biological potency.
  181. Schmidt, Scott C.; Mendolia, Michael S.; Callais, Peter A., Polymer encapsulation and/or binding.
  182. Kochendoerfer,Gerd G.; Botti,Paolo; Bradburne,James A.; Chen,Shiah yun; Cressman,Sonya; Hunter,Christie L.; Kent,Stephen B. H.; Low,Donald W.; Wilken,Jill G., Polymer-modified synthetic proteins.
  183. Kausch, Annemie Rehor; Cerritelli, Simona, Polymeric tissue sealant.
  184. Rehor, Annemie; Cerritelli, Simona, Polymeric tissue sealant.
  185. Ladner, Robert C.; Ley, Arthur C.; Hirani, Shirish; Williams, Anthony, Prevention and reduction of blood loss.
  186. Ladner, Robert C.; Ley, Arthur C.; Hirani, Shirish; Williams, Anthony, Prevention and reduction of blood loss.
  187. Ladner, Robert Charles; Ley, Arthur Charles; Hirani, Shirish; Williams, Anthony, Prevention and reduction of blood loss.
  188. Faure,Marie Pierre; Ibea,Micheal, Process for the preparation of activated polyethylene glycols.
  189. Faure,Marie Pierre; Shingel,Kirill, Process for the preparation of activated polyethylene glycols.
  190. Faure, Marie-Pierre; Shingel, Kirill, Process for the preparation of activated polythylene glycols.
  191. DeFrees, Shawn; Bowe, Caryn, Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography.
  192. Weisgerber, David John; Rubingh, Donn Nelton; Correa, Paul Elliott, Protease conjugates having sterically protected clip sites.
  193. Rubingh, Donn Nelton; Weisgerber, David John; Correa, Paul Elliott, Protease conjugates having sterically protected epitope regions.
  194. David John Weisgerber ; Donn Nelton Rubingh ; Paul Elliott Correa, Proteases having modified amino acid sequences conjugated to addition moieties.
  195. DeFrees, Shawn; Zopf, David; Bayer, Robert; Hakes, David; Chen, Xi, Protein remodeling methods and proteins/peptides produced by the methods.
  196. Pathak,Chandrashekhar P., Proteinaceous gels having visualization agents and methods of use thereof.
  197. Godwin, Antony, Reagents and method for conjugating biological molecules.
  198. Godwin, Antony, Reagents and method for conjugating biological molecules.
  199. Godwin, Antony, Reagents and method for conjugating biological molecules.
  200. Kraynov, Vadim; Knudsen, Nick; Hewet, Ahma; De Dios, Kristine; Pinkstaff, Jason; Sullivan, Lorraine, Relaxin polypeptides comprising non-naturally encoded amino acids.
  201. Kraynov, Vadim; Knudsen, Nick; Hewet, Ahma; De Dios, Kristine; Pinkstaff, Jason; Sullivan, Lorraine, Relaxin polypeptides comprising non-naturally encoded amino acids.
  202. DeFrees, Shawn, Remodeling and glycopegylation of fibroblast growth factor (FGF).
  203. Rubingh, Donn Nelton; Sikorski, Elizabeth Ellen; Correa, Paul Elliott, Serine protease variants having amino acid deletions and substitutions.
  204. Rubingh, Donn Nelton; Sikorski, Elizabeth Ellen; Correa, Paul Elliott, Serine protease variants having amino acid substitutions.
  205. Hinds, Kenneth; Lewis, Danny; Schmidt, Paul; Campbell, Kathleen M., Site-specific insulin-polymer conjugates.
  206. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  207. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  208. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  209. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  210. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  211. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  212. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  213. Bookbinder, Louis; Kundu, Anirban; Frost, Gregory I., Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases.
  214. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof.
  215. Bookbinder, Louis H.; Kundu, Anirban; Frost, Gregory I., Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof.
  216. Bookbinder, Louis H.; Kundu, Anirbau; Frost, Gregory I., Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof.
  217. Bookbinder, Louis; Kundu, Anirban; Frost, Gregory I., Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof.
  218. Dave , Kirti I.; Fernandez, Brian Robert, Stabilization of cardiac troponin I subunits and complexes.
  219. Dav챕,Kirti I.; Fern찼ndez,Brian Robert, Stabilization of cardiac troponin I subunits and complexes.
  220. Leshchiner, Elizaveta; Walensky, Loren D., Stabilized SOS1 peptides.
  221. Walensky, Loren D.; Bird, Gregory H., Stabilized antiviral fusion helices.
  222. Dave Kirti I. ; Botyanszki Janos ; Sintar Eva, Stabilized conjugates of uncomplexed subunits of multimeric proteins.
  223. Kirti I. Dave ; Janos Botyanszki ; Eva Sintar, Stabilized conjugates of uncomplexed subunits of multimeric proteins.
  224. Kozlowski, Antoni; McManus, Samuel, Stabilized polymeric thiol reagents.
  225. Kozlowski, Antoni; McManus, Samuel P., Stabilized polymeric thiol reagents.
  226. Kozlowski, Antoni; McManus, Samuel P., Stabilized polymeric thiol reagents.
  227. Kozlowski, Antoni; McManus, Samuel P., Stabilized polymeric thiol reagents.
  228. Kozlowski, Antoni; McManus, Samuel P., Stabilized polymeric thiol reagents.
  229. Teschner, Wolfgang; Svatos, Sonja; Bruckschwaiger, Leopold; Weber, Alfred; Schwarz, Hans-Peter; Lei, Laura, Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof.
  230. Yang, Tzung-Horng; Vaughn, Daniel Edward; Labarre, Michael James; Caster, Christopher L.; Nicol, Francois; Kim, Donghyun, Stable formulations of a hyaluronan-degrading enzyme.
  231. Rubingh, Donn Nelton; Sikorski, Elizabeth Ellen, Subtilisin protease variants having amino acid deletions and substitutions in defined epitope regions.
  232. Sikorski, Elizabeth Ellen; Rubingh, Donn Nelton, Subtilisin protease variants having amino acid substitutions in defined epitope regions.
  233. Frost, Gregory I.; Bilinsky, Igor; Vaughn, Daniel; Sugarman, Barry, Super fast-acting insulin compositions.
  234. Tian, Feng; Norman, Thea; Chu, Stephanie, Suppressor tRNA transcription in vertebrate cells.
  235. Hadba, Ahmad R.; Kennedy, John; Roby, Mark, Synthetic sealants.
  236. Klink, Tony; Kink, John; Strong, Laura, Therapeutic ribonucleases.
  237. Klink, Tony; Kink, John; Strong, Laura, Therapeutic ribonucleases.
  238. Klink, Tony; Kink, John; Strong, Laura, Therapeutic ribonucleases.
  239. Klink, Tony; Kink, John; Strong, Laura, Therapeutic ribonucleases.
  240. Klink, Tony; Kink, John; Strong, Laura, Therapeutic ribonucleases.
  241. Morin, Paul E.; Cohen, Daniel; Mukherjee, Ranjan; Reilly, Timothy P.; Christian, Rose C.; Lipovsek, Dasa; Camphausen, Ray; Krupinski, John, Therapeutic uses of modified FGF-21 polypeptides.
  242. Kraynov, Vadim; Knudsen, Nick; Hewet, Amha; De Dios, Kristine; Pinkstaff, Jason; Sullivan, Lorraine, Therapeutic uses of modified relaxin polypeptides.
  243. Kraynov, Vadim; Knudsen, Nick; Hewet, Amha; de Dios, Kristine; Pinkstaff, Jason; Sullivan, Lorraine, Therapeutic uses of modified relaxin polypeptides.
  244. Kozlowski, Antoni; Gross, III, Remy F.; McManus, Samuel P., Thiol-selective water-soluble polymer derivatives.
  245. Kozlowski, Antoni; Gross, III, Remy F.; McManus, Samuel P., Thiol-selective water-soluble polymer derivatives.
  246. Kozlowski, Antoni; Gross, III, Remy F.; McManus, Samuel P., Thiol-selective water-soluble polymer derivatives.
  247. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P.; Nguyen, Hung Q.; Walker, Kenneth W.; Hu, Shaw-Fen Sylvia; Gegg, Colin V.; McDonough, Stefan I., Toxin peptide therapeutic agents.
  248. Sullivan, John K.; McGivern, Joseph G.; Miranda, Leslie P.; Nguyen, Hung Q.; Walker, Kenneth W.; Hu, Shaw-Fen Sylvia; Gegg, Colin V.; McDonough, Stefan I., Toxin peptide therapeutic agents.
  249. Sternlicht, Andrew, Treatment of mucositis with kallikrein inhibitors.
  250. Segura, Tatiana; Hubbell, Jeffrey A., Triblock copolymers for cytoplasmic delivery of gene-based drugs.
  251. Fisher,Eric F.; Edwards, III,Carl K.; Kieft,Gary L., Truncated soluble tumor necrosis factor type-I and type-II receptors.
  252. Brewer Michael T. ; Hale Karin K. ; King Michael W. ; Kohno Tadahiko ; Squires Charles ; Thompson Robert C. ; Vanderslice Rebecca W. ; Vannice James, Tumor necrosis factor (TNF) inhibitor and method for obtaining the same.
  253. Miranda, Leslie Philip; Kent, Stephen B. H., Water-soluble thioester and selenoester compounds and methods for making and using the same.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로